CIK 0001798749
- Emerging growth company
Jade Biosciences, Inc.
Sign in to watch- Ticker
- JBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 831377888
- Phone
- +1 781-312-3013
- Business address
- 221 CRESCENT ST., BUILDING 23, SUITE 105, WALTHAM, MA, 02453
- Former names
- Aerovate Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 84 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-07-28 | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER | Option exercise 10b5-1 | +5,478 | $2.14 | $12K | 5,478 |
| 2023-07-28 | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −5,478 | $18.00 | $99K | 0 |
| 2023-07-28 | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER | Option exercise · Stock Option (Right to Buy) 10b5-1 | −5,478 | 383,381 | ||
| 2023-07-17 | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER | Option exercise 10b5-1 | +4,522 | $2.14 | $10K | 4,522 |
| 2023-07-17 | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −4,522 | $18.11 | $82K | 0 |
| 2023-07-17 | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER | Option exercise · Stock Option (Right to Buy) 10b5-1 | −4,522 | 388,859 | ||
| 2023-07-10 | Dable Habib J Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2023-07-06 | Dake Benjamin T SEE REMARKS | Option exercise 10b5-1 | +2,412 | $1.74 | $4K | 3,703 |
| 2023-07-06 | Dake Benjamin T SEE REMARKS | Option exercise 10b5-1 | +7,871 | $2.14 | $17K | 11,574 |
| 2023-07-06 | Dake Benjamin T SEE REMARKS | Sale 10b5-1 | −10,283 | $16.66 | $171K | 1,291 |
| 2023-07-06 | Dake Benjamin T SEE REMARKS | Option exercise · Stock Option (Right to Buy) 10b5-1 | −906 | 5,433 | ||
| 2023-07-06 | Dake Benjamin T SEE REMARKS | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,506 | 19,589 | ||
| 2023-07-06 | Dake Benjamin T SEE REMARKS | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,019 | 21,386 | ||
| 2023-07-06 | Dake Benjamin T SEE REMARKS | Option exercise · Stock Option (Right to Buy) 10b5-1 | −6,852 | 157,609 | ||
| 2023-07-05 | NIVEN RALPH CHIEF SCIENTIFIC OFFICER | Option exercise 10b5-1 | +650 | $1.74 | $1K | 2,259 |
| 2023-07-05 | NIVEN RALPH CHIEF SCIENTIFIC OFFICER | Option exercise 10b5-1 | +1,600 | $2.14 | $3K | 3,859 |
| 2023-07-05 | NIVEN RALPH CHIEF SCIENTIFIC OFFICER | Sale 10b5-1 | −2,031 | $17.23 | $35K | 1,828 |
| 2023-07-05 | NIVEN RALPH CHIEF SCIENTIFIC OFFICER | Sale 10b5-1 | −219 | $17.87 | $4K | 1,609 |
| 2023-07-05 | NIVEN RALPH CHIEF SCIENTIFIC OFFICER | Option exercise · Stock Option (Right to Buy) 10b5-1 | −450 | 18,708 | ||
| 2023-07-05 | NIVEN RALPH CHIEF SCIENTIFIC OFFICER | Option exercise · Stock Option (Right to Buy) 10b5-1 | −200 | 12,088 |
Page 14 of 16 · 315 trades